Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

U6 snRNA maturation and stability

M G Fury1, G W Zieve

  • 1Department of Pathology, State University of New York, Stony Brook 11794-8691, USA.

Experimental Cell Research
|October 10, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells.

Leukemia·2015
Same author

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same journal

Retraction notice to "Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway" [Exp. Cell Res. 361 (2017) 342-352].

Experimental cell research·2026
Same journal

METTL3-Mediated m<sup>6</sup>A Modification Stabilizes COL1A1 mRNA to Promote Extracellular Matrix Accumulation in Keloids.

Experimental cell research·2026
Same journal

Early-Life Cardiovascular Programming by Maternal Protein Restriction: Electrophysiological, Structural, and Molecular Alterations in Female Rats.

Experimental cell research·2026
Same journal

The AP2α/PDHA1 signaling pathway promotes lung cancer progression by mediating aerobic glycolysis and inhibiting cuproptosis.

Experimental cell research·2026
Same journal

Distributed transcription activity in DLX proteins defies conventional mapping of a transcription activation domain.

Experimental cell research·2026
Same journal

Extracellular release of cytotoxic aggregates from HSV-1-replicating SH-SY5Y cells: involvement of alpha-synuclein and poly-ubiquitin conjugates.

Experimental cell research·2026
See all related articles

Newly synthesized U6 small nuclear RNA (snRNA) matures in the cytoplasm before nuclear import, independent of U4 snRNA. This distinct cytoplasmic pathway precedes U4/U6 snRNP assembly in the nucleus.

Area of Science:

  • Molecular Biology
  • RNA Biology
  • Cell Biology

Background:

  • The U6 small nuclear ribonucleoprotein particle (snRNP) exists as a monomer and a U4/U6 heterodimer.
  • Nuclear U6 snRNP is detected as both monomer and U4/U6 heterodimer, while cytoplasmic U6 is primarily monomeric.

Purpose of the Study:

  • To investigate the cytoplasmic maturation and nuclear import pathways of U6 snRNA.
  • To elucidate the distinct roles of cytoplasmic and nuclear compartments in U6 snRNP biogenesis.

Main Methods:

  • Northern blotting to detect U6 and U4/U6 heterodimers in nuclear and cytoplasmic fractions.
  • Sedimentation analysis to determine the size of cytoplasmic U6-containing structures.
  • Inhibitor studies to assess the dependence of U6 nuclear import on U4 synthesis.

Related Experiment Videos

Main Results:

  • Newly synthesized U6 transiently appears in the cytoplasm before nuclear return.
  • Cytoplasmic U6 exists in structures similar in size to nuclear U4/U6 but smaller than cytoplasmic U4.
  • U6 can enter the nucleus independently of U4 synthesis.
  • U6 exhibits a significantly shorter nuclear half-life compared to U4 and other spliceosomal snRNAs.

Conclusions:

  • U4 and U6 snRNAs follow distinct cytoplasmic maturation pathways.
  • Cytoplasmic maturation precedes nuclear import and subsequent U4/U6 snRNP assembly.
  • This model highlights compartmentalized biogenesis of spliceosomal components.